Tag: Astrazeneca
AstraZeneca: a new positive opinion from the CHMP for Lynparza
(CercleFinance.com) – The European Medicines Agency announced on Friday that its Committee for Medicinal Products for Human Use (CHMP) had issued a positive opinion on a new indication for Lynparza,…
AstraZeneca: positive results in Wilson’s disease
(CercleFinance.com) – AstraZeneca presented on Thursday the detailed results of a phase III clinical study concerning the ALXN1840 tablet in the treatment of Wilson’s disease. The biopharmaceutical group indicates that…
AstraZeneca: Good results in prostate cancer
(CercleFinance.com) – A phase III clinical study has shown that Lynparza, the cancer drug developed by AstraZeneca and Merck, ‘significantly’ improved the progression-free survival of patients with prostate cancer .…
AstraZeneca: good results in prostate cancer
(CercleFinance.com) – A phase III clinical study has shown that Lynparza, the cancer drug developed by AstraZeneca and Merck, ‘significantly’ improved the progression-free survival of patients with prostate cancer .…
AstraZeneca: in slight decline, an analyst downgrades his advice
(CercleFinance.com) – AstraZeneca loses just under 1% in London, penalized by an analysis by UBS which lowers its recommendation on the stock from ‘buy’ to ‘neutral’ while lowering its price…
AstraZeneca releases positive new data on its anti-Covid drug
Europe 1 with AFP 4:12 p.m., June 08, 2022 The pharmaceutical group AstraZeneca has published new positive data on the test of the anti-Covid-19 drug named Evusheld. Tested in Europe,…
ASTRAZENECA: Positive opinion of Berenberg
In a research note published by Luisa Hector, the broker Berenberg advises to be interested in the title with an opinion on…
Cancer: AstraZeneca gives itself five years to become world number one
The price of the British laboratory, which had embarked on the battle of Covid with the University of Oxford, has quadrupled in ten years. “Ten years ago, we started almost…
AstraZeneca: New positive results for Enhertu
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
AstraZeneca: towards a new study with Innate
(CercleFinance.com) – Innate Pharma announces that IPH5201, its monoclonal antibody directed against CD39, developed in partnership with AstraZeneca, will advance to a phase 2 clinical trial in lung cancer. The…
AstraZeneca: first patients in lupus nephritis
(CercleFinance.com) – AstraZeneca announced on Friday that the first patients had been dosed as part of its phase 3 clinical trial to evaluate the antibody anifrolumab in the treatment of…
AstraZeneca: green light for Vaxzevria as a recall in the EU
(CercleFinance.com) – AstraZeneca says its Covid-19 vaccine, Vaxzevria, has been approved in the European Union (EU) by the European Medicines Agency (EMA) as a third dose booster in adult. Healthcare…